Food and Drug Regulations, C.R.C., c. 870

Section C.01.014.91

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.01.014.91 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) If the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for a drug decides to discontinue the sale of the drug, they shall post the following information in English and French on the designated website: (a) the manufacturer’s name and contact information; (b) the drug identification number assigned for the drug; (c) the drug’s brand name and proper name or, if it does not have a proper name, its common name; (d) the proper names of the drug’s medicinal ingredients or, if they do not have proper names, their common names; (e) the drug’s therapeutic classification according to the Anatomical Therapeutic Chemical classification system (ATC), established by the World Health Organization Collaborating Centre for Drug Statistics Methodology — namely the level 3 description of, and level 4 code for, the drug; (f) the drug’s strength; (g) the drug’s dosage form; (h) the quantity of the drug contained in its package; (i) the drug’s route of administration; (j) the date on which the manufacturer will discontinue the sale of the drug; and (k) the reason for the discontinuation of sale. (2) The manufacturer shall post the information (a) if they decide to discontinue the sale of the drug in more than 12 months, at least 12 months before the day on which they will discontinue its sale; and (b) if they decide to discontinue the sale of the drug in 12 months or less, within five days after the day on which they make that decision. (3) If any of the information that was posted by the manufacturer changes, they shall update that information on the designated website within five days after the day on which they make or become aware of the change. (4) For greater certainty, subsection (1) does not remove the requirement for the manufacturer to inform the Minister under section C.01.014.7.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.